지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Background: Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in post-transplantation maintenance therapy. The drug has a narrow therapeutic range and requires periodic therapeutic drug monitoring. Although many studies have reported the effects of intrapatient variability of tacrolimus on survival, rejection, and complications in renal transplant recipients, very few studies have reported these effects in liver transplant recipients. The purpose of this study was to evaluate the effect of intrapatient variability of tacrolimus on clinical outcomes after liver transplantation. Methods: Intrapatient variability was calculated using individual, averaged tacrolimus concentrations. Patients were divided into two groups according to their median variability value: high-variability and low-variability groups. The rate of deviation from the therapeutic range, incidence of acute rejection, posttransplant diabetes, incidence of infection, and estimated glomerular filtration rate (eGFR) after transplantation were compared between the groups. Results: Of the total patients (n=82), the high-variability group (n=41) exhibited significantly greater deviation from the therapeutic range (65.92% vs. 56.84%; p<0.001). There was no significant difference in acute rejection or posttransplantation diabetes incidence or eGFR; however, the number of infection in the first 6 months was significantly lower in the low-variability group (0.4 vs. 0.9 times; p=0.039). Multiple linear regression analysis showed that the number of infection significantly increased as intrapatient variability increased (p=0.015). Conclusion: High intrapatient variability in tacrolimus concentrations was strongly associated with an increased frequency of deviation from the suggested therapeutic range and an increased number of infection.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Efficacy and safety of a switch from twice- daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
Clinical Transplantation and Research
2021 .09
-
폐이식 환자에서 tacrolimus와 itraconazole 혹은 voriconazole 병용 시 tacrolimus의 혈중 농도 변화에 미치는 영향
한국임상약학회지
2016 .12
-
비만환자의 조혈모세포이식 후 체중 적용 기준에 따른 Tacrolimus 초기 농도 비교
병원약사회지
2021 .01
-
The optimal tacrolimus trough level after liver transplantation
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
1일 2회 투여하는 Tacrolimus에서 1일 1회 투여하는 서방형 Tacrolimus로 전환 시 대응 용량비의 적절성 평가
병원약사회지
2020 .01
-
Evaluation of the efficacy and safety of conversion from the tacrolimus capsule to tablet in stable liver transplant recipients with maintenance therapy: a 24-week, open-label, single-center, phase IV exploratory clinical study
Annals of Surgical Treatment and Research
2023 .10
-
신장이식 환자에서 Chemiluminescence Microparticle Immunoassay를 이용한 검사상 Tacrolimus 농도 위증가를 보인 1예
Clinical Transplantation and Research
2016 .01
-
Preventive effect of tacrolimus on patients with post- endoscopic retrograde cholangiopancreatography pancreatitis
Clinical Endoscopy
2022 .09
-
신장이식 환자에서 타크로리무스에 의한 발열
대한내과학회지
2019 .06
-
Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
Yonsei Medical Journal
2019 .01
-
Flat Pattern Peaks of Tacrolimus Absorption and Associated Pharmacogenomic Variants in Kidney Transplantation Recipients
Journal of Korean Medical Science
2022 .02
-
칼시뉴린 억제제에 의하여 유발된 다발성 뇌경색
Clinical Transplantation and Research
2016 .01
-
Clinical Implications of Glucose Variability: Chronic Complications of Diabetes
Endocrinology and Metabolism
2015 .01
-
Effectiveness and Safety of Tacrolimus in Patients with Active Rheumatoid Arthritis with Inadequate Response to Disease-modifying Anti-rheumatic Drugs: The TREASURE Study
대한류마티스학회지
2019 .01
-
Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan
Intestinal research
2019 .01
-
Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy
Annals of Hepato-Biliary-Pancreatic Surgery
2017 .02
-
면역학적 고위험도 신장이식 환자에서 Sirolimus와 Tacrolimus 조합: 이식 후 3년 추적 관찰 결과
Clinical Transplantation and Research
2016 .01
-
Incidence of Topical Tacrolimus Adverse Effects in Chronic Skin Disease
Annals of Dermatology
2019 .01
-
Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
Journal of Korean Medical Science
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0